BNF for Children March 2023 Update

This update contains 1 significant change, 2 dose changes, 2 new monographs, and 1 new preparation.

Significant Changes:

• Genital system infections, antibacterial therapy: updated guidance for the management of uncomplicated genital chlamydia and gonorrhoea.

Dose Change:

• Azithromycin [update to dosing for uncomplicated genital chlamydia in children from 12 years old, and update to include dosing in children from 12 years old for uncomplicated gonorrhoea].
• Ceftriaxone [update to dosing for pelvic inflammatory disease in children from 12 years old, and update to dosing for uncomplicated gonorrhoea and congenital gonococcal conjunctivitis].

New Monographs:

• Tezspire® [tezepelumab].
• Xenpozyme® [olipudase alfa].

New Preparations:

• DuoResp Spiromax® [budesonide with formoterol].